Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uric Acid | 6 | 2024 | 805 | 1.210 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2024 | 105 | 1.040 |
Why?
|
| Hyperuricemia | 3 | 2023 | 222 | 0.890 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2024 | 386 | 0.800 |
Why?
|
| Xenopus laevis | 2 | 2024 | 967 | 0.720 |
Why?
|
| Uteroglobin | 7 | 2005 | 56 | 0.680 |
Why?
|
| Caffeine | 1 | 2024 | 703 | 0.670 |
Why?
|
| Hyperinsulinism | 1 | 2023 | 402 | 0.670 |
Why?
|
| Adenosine | 1 | 2024 | 820 | 0.660 |
Why?
|
| Organic Anion Transporters | 3 | 2024 | 101 | 0.510 |
Why?
|
| Receptors, Prostaglandin | 2 | 2005 | 53 | 0.480 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2024 | 57 | 0.440 |
Why?
|
| Homeostasis | 5 | 2023 | 3348 | 0.390 |
Why?
|
| Phospholipases A | 3 | 2001 | 204 | 0.370 |
Why?
|
| Molecular Biology | 1 | 2014 | 573 | 0.360 |
Why?
|
| Insulin | 1 | 2024 | 6607 | 0.340 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2008 | 128 | 0.300 |
Why?
|
| Gout | 3 | 2020 | 621 | 0.300 |
Why?
|
| Nuclear Envelope | 1 | 2008 | 163 | 0.290 |
Why?
|
| Leukotrienes | 1 | 2008 | 232 | 0.280 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 2 | 2024 | 28 | 0.270 |
Why?
|
| Prostaglandins | 1 | 2005 | 398 | 0.230 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2024 | 61 | 0.230 |
Why?
|
| Pancreas | 2 | 2001 | 1700 | 0.230 |
Why?
|
| Leukotriene C4 | 1 | 2004 | 79 | 0.220 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 1110 | 0.200 |
Why?
|
| Oocytes | 2 | 2024 | 1172 | 0.190 |
Why?
|
| Cyclooxygenase 2 | 5 | 2005 | 598 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2024 | 567 | 0.180 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2004 | 319 | 0.180 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 931 | 0.170 |
Why?
|
| Biological Transport | 1 | 2024 | 2085 | 0.170 |
Why?
|
| Sphingolipids | 1 | 2001 | 178 | 0.170 |
Why?
|
| Carrier Proteins | 3 | 2008 | 4937 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 1418 | 0.150 |
Why?
|
| Membrane Proteins | 4 | 2008 | 7876 | 0.140 |
Why?
|
| Phospholipids | 1 | 2001 | 787 | 0.140 |
Why?
|
| Isoenzymes | 4 | 2004 | 1688 | 0.140 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 2008 | 24 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 1904 | 0.140 |
Why?
|
| Inflammation | 3 | 2005 | 10873 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2005 | 11928 | 0.130 |
Why?
|
| Cell Line | 3 | 2024 | 15597 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 1942 | 0.120 |
Why?
|
| Receptors, Cell Surface | 2 | 2001 | 2819 | 0.120 |
Why?
|
| Genetic Markers | 2 | 2020 | 2603 | 0.120 |
Why?
|
| Azospirillum brasilense | 1 | 1993 | 2 | 0.110 |
Why?
|
| Glutamate Synthase | 1 | 1993 | 3 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 2457 | 0.110 |
Why?
|
| NIH 3T3 Cells | 2 | 2005 | 669 | 0.110 |
Why?
|
| 3T3 Cells | 4 | 2004 | 1084 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2885 | 0.110 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 12795 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2005 | 1550 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2004 | 1169 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 3603 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 2131 | 0.100 |
Why?
|
| Genes, Bacterial | 2 | 1998 | 1076 | 0.090 |
Why?
|
| Animals | 17 | 2024 | 169246 | 0.090 |
Why?
|
| Mice | 14 | 2008 | 82029 | 0.070 |
Why?
|
| Prostaglandins A | 1 | 2005 | 13 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2005 | 12800 | 0.060 |
Why?
|
| Prostaglandin D2 | 1 | 2005 | 108 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2017 | 5027 | 0.060 |
Why?
|
| Phospholipases A2 | 2 | 2001 | 197 | 0.060 |
Why?
|
| Energy Transfer | 1 | 2004 | 109 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 429 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2008 | 839 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2005 | 319 | 0.050 |
Why?
|
| Arthritis | 1 | 2008 | 684 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2020 | 16045 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 462 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 3 | 2000 | 3620 | 0.050 |
Why?
|
| Galactosylgalactosylglucosylceramidase | 1 | 2001 | 4 | 0.050 |
Why?
|
| Base Sequence | 5 | 2001 | 12421 | 0.050 |
Why?
|
| Protein Binding | 3 | 2005 | 9343 | 0.050 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2001 | 32 | 0.050 |
Why?
|
| Uterus | 1 | 2005 | 663 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 665 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2001 | 83 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 702 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2014 | 23645 | 0.040 |
Why?
|
| Humans | 16 | 2024 | 768166 | 0.040 |
Why?
|
| Bronchi | 1 | 2004 | 850 | 0.040 |
Why?
|
| Chromosome Mapping | 4 | 2001 | 4620 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2001 | 268 | 0.040 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2000 | 81 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2005 | 3956 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2001 | 13421 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2000 | 160 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 432 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2004 | 6514 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1999 | 4168 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2001 | 17622 | 0.040 |
Why?
|
| Thiolester Hydrolases | 1 | 1999 | 91 | 0.040 |
Why?
|
| Cosmids | 2 | 1998 | 105 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 887 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 18065 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1999 | 134 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1999 | 411 | 0.040 |
Why?
|
| Organic Anion Transport Protein 1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 1162 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6124 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1252 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2005 | 5403 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1998 | 849 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2005 | 2493 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2633 | 0.030 |
Why?
|
| New Zealand | 1 | 2017 | 360 | 0.030 |
Why?
|
| Allergens | 1 | 2004 | 1443 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 1998 | 570 | 0.030 |
Why?
|
| Cysteine | 1 | 2001 | 897 | 0.030 |
Why?
|
| Neutrophils | 1 | 2008 | 3786 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 873 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2720 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 1363 | 0.030 |
Why?
|
| Blindness | 1 | 1999 | 587 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 1676 | 0.030 |
Why?
|
| Genes | 1 | 1998 | 1824 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4176 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2004 | 3655 | 0.030 |
Why?
|
| Nitrogenase | 1 | 1993 | 38 | 0.030 |
Why?
|
| Extracellular Matrix | 2 | 2000 | 1738 | 0.030 |
Why?
|
| Ammonium Chloride | 1 | 1993 | 72 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 2748 | 0.030 |
Why?
|
| Mutation | 2 | 2000 | 30238 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3703 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7598 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 1998 | 796 | 0.030 |
Why?
|
| Glutamates | 1 | 1993 | 385 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2005 | 19015 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6231 | 0.020 |
Why?
|
| Vibrio cholerae | 1 | 1998 | 793 | 0.020 |
Why?
|
| Swine | 1 | 2001 | 5995 | 0.020 |
Why?
|
| Gene Library | 1 | 1993 | 1064 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22291 | 0.020 |
Why?
|
| Glutamine | 1 | 1993 | 577 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2271 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 3610 | 0.020 |
Why?
|
| Female | 4 | 2023 | 397192 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2846 | 0.020 |
Why?
|
| Retina | 1 | 1999 | 2662 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1993 | 1191 | 0.020 |
Why?
|
| Cell Movement | 1 | 2000 | 5210 | 0.020 |
Why?
|
| Male | 3 | 2023 | 364719 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 5797 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4786 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 1999 | 1989 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 5926 | 0.010 |
Why?
|
| Cytokines | 1 | 1999 | 7453 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40218 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13290 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1999 | 6395 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1993 | 4214 | 0.010 |
Why?
|
| Ceramidases | 1 | 2000 | 4 | 0.010 |
Why?
|
| Acid Ceramidase | 1 | 2000 | 21 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2000 | 366 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.010 |
Why?
|
| Mice, Knockout | 3 | 1999 | 14488 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 287 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 258 | 0.010 |
Why?
|
| Genomic Library | 1 | 1998 | 189 | 0.010 |
Why?
|
| DNA Primers | 1 | 2000 | 2828 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 7608 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1998 | 562 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 1062 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 2521 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1999 | 1230 | 0.010 |
Why?
|
| Species Specificity | 1 | 1998 | 2415 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 3055 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1998 | 1478 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 3819 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 27360 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4580 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5755 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1999 | 1424 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9561 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 5804 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 223492 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9615 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 223646 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16726 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 11101 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 13586 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 21206 | 0.000 |
Why?
|
Concepts
(185)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_